Follow WeChat

CN EN

Pipeline

Dosage form and approval by CDEindication
Pre-Clinical
IND-Enabling
Phase I
Phase II
Phase III
Right
CF04
Eye drops
Dry Eye disease
Completed
2024Q2
2025Q3
Global
CF04
Eye drops
Allergic conjunctivitis
Completed
2025Q2
2026Q2
Global
APP
Long acting Injectable
Diabetic neuropathy pain
Completed
2024Q3
2025Q3
Global
APP
IV injection
Cancer-related pain
Completed
2024Q3
2025Q3
Global
CopyRight © 2022 Shanghai Amphiprotech Co.,Ltd 沪ICP备2022028040号
Powered by SE